These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26195725)

  • 1. Identification of resolvin D2 receptor mediating resolution of infections and organ protection.
    Chiang N; Dalli J; Colas RA; Serhan CN
    J Exp Med; 2015 Jul; 212(8):1203-17. PubMed ID: 26195725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Resolvin D2 Receptor Axis in Infectious Inflammation.
    Chiang N; de la Rosa X; Libreros S; Serhan CN
    J Immunol; 2017 Jan; 198(2):842-851. PubMed ID: 27994074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolvin D2 limits atherosclerosis progression via myeloid cell-GPR18.
    Lipscomb M; Walis S; Marinello M; Mena HA; MacNamara KC; Spite M; Fredman G
    FASEB J; 2024 Mar; 38(6):e23555. PubMed ID: 38498346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron PA; Sharma AK; Upchurch GR
    FASEB J; 2024 Sep; 38(18):e70067. PubMed ID: 39320982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Chemotype Agonists for Human Resolvin D1 Receptor DRV1 with Pro-Resolving Functions.
    Chiang N; Barnaeva E; Hu X; Marugan J; Southall N; Ferrer M; Serhan CN
    Cell Chem Biol; 2019 Feb; 26(2):244-254.e4. PubMed ID: 30554914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice.
    Bardin M; Pawelzik SC; Lagrange J; Mahdi A; Arnardottir H; Regnault V; Fève B; Lacolley P; Michel JB; Mercier N; Bäck M
    Biochem Pharmacol; 2022 Jul; 201():115075. PubMed ID: 35525326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolvin D2 and its receptor GPR18 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target.
    Zhao M; Zheng Z; Yin Z; Zhang J; Qin J; Wan J; Wang M
    Pharmacol Res; 2023 Sep; 195():106832. PubMed ID: 37364787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.
    Zhang MJ; Sansbury BE; Hellmann J; Baker JF; Guo L; Parmer CM; Prenner JC; Conklin DJ; Bhatnagar A; Creager MA; Spite M
    Circulation; 2016 Aug; 134(9):666-680. PubMed ID: 27507404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis.
    Spite M; Norling LV; Summers L; Yang R; Cooper D; Petasis NA; Flower RJ; Perretti M; Serhan CN
    Nature; 2009 Oct; 461(7268):1287-91. PubMed ID: 19865173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections.
    Flak MB; Koenis DS; Sobrino A; Smith J; Pistorius K; Palmas F; Dalli J
    J Clin Invest; 2020 Jan; 130(1):359-373. PubMed ID: 31793912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPR18 Agonist Resolvin D2 Reduces Early Brain Injury in a Rat Model of Subarachnoid Hemorrhage by Multiple Protective Mechanisms.
    Zhang T; Zuo G; Zhang H
    Cell Mol Neurobiol; 2022 Oct; 42(7):2379-2392. PubMed ID: 34089427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolvin D2-GPR18 Signaling on Myeloid Cells Limits Plaque Necrosis.
    Lipscomb M; Walis S; Marinello M; Mena HA; Spite M; Fredman G
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolvin D2/GPR18 signaling enhances monocytic myeloid-derived suppressor cell function to mitigate abdominal aortic aneurysm formation.
    Bellotti P; Ladd Z; Leroy V; Su G; Sharma S; Hartman JB; Krebs J; Viscardi C; Maile R; Moldawer LL; Efron P; Sharma AK; Upchurch GR
    bioRxiv; 2024 Feb; ():. PubMed ID: 38464077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions.
    Chiang N; Libreros S; Norris PC; de la Rosa X; Serhan CN
    J Clin Invest; 2019 Dec; 129(12):5294-5311. PubMed ID: 31657786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.
    Croasdell A; Sime PJ; Phipps RP
    FASEB J; 2016 Sep; 30(9):3181-93. PubMed ID: 27256622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolvin D1 binds human phagocytes with evidence for proresolving receptors.
    Krishnamoorthy S; Recchiuti A; Chiang N; Yacoubian S; Lee CH; Yang R; Petasis NA; Serhan CN
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1660-5. PubMed ID: 20080636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors.
    Rodrigues-Diez R; Ballesteros-Martinez C; Moreno-Carriles RM; Nistal F; Díaz Del Campo LS; Cachofeiro V; Dalli J; García-Redondo AB; Redondo JM; Salaices M; Briones AM
    Biomed Pharmacother; 2024 May; 174():116564. PubMed ID: 38608525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvin D2 uses multiple Ca
    Botten N; Hodges RR; Bair J; Utheim TP; Serhan CN; Yang M; Dartt DA
    J Cell Physiol; 2022 Oct; 237(10):3816-3833. PubMed ID: 36066128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
    Orr SK; Colas RA; Dalli J; Chiang N; Serhan CN
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(9):L904-11. PubMed ID: 25770181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Resolvin D2-GPR18 Axis Enhances Bone Marrow Function and Limits Hepatic Fibrosis in Aging.
    Fitzgerald H; Bonin JL; Sadhu S; Lipscomb M; Biswas N; Decker C; Nabage M; Bossardi R; Marinello M; Mena AH; Gilliard K; Spite M; Adam A; MacNamara KC; Fredman G
    bioRxiv; 2023 Jan; ():. PubMed ID: 36711905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.